Strategy and targets

Oriola’s purpose, 'Health for life', guides our operations together with our vision and mission. Our goal is to enable a healthier tomorrow by providing sustainable health and wellbeing products and services.

Clear strategic direction

After the successful implementation of Oriola's short-term turnaround and the restructuring of Oriola's business portfolio in 2022, Oriola will continue with its long-term transformation to achieve the company's full potential.

Oriola has a clear strategic direction that focuses on our core business, the improvement of profitability and our societal role as an infrastructure company in securing the availability of pharmaceuticals.

We want to be the preferred business partner in the Nordics, and we offer high-quality and advanced distribution of pharmaceuticals and a wide assortment of health and wellbeing products to our customers. In addition, we provide advisory services to pharmaceutical companies and pharmacies.

To ensure sustainable growth and shareholder value, Oriola further develops its commercial and supply chain excellence while ensuring profitability, efficiency and a collaborative culture. Oriola will also support the value creation in its joint venture company Kronans Apotek and gradually look for selective merger and acquisition targets to support Oriola's growth.

Long-term financial targets¹

• Business growth at the rate of market growth
• Annual EPS growth over 5 per cent, without adjusting items
• Return on capital employed of over 20 per cent
• Adjusted gearing ratio of lower than 70 per cent²

¹ Calculated excluding the impact of application of IFRS 16
² Non-recourse trade receivables are added to the net debt

Long-term sustainability goals

• Improving people’s health
• Best-in-class employee engagement
• Carbon neutrality by 2030

As a health and wellbeing company, sustainability is at the core of our operations: we promote the health of people and the entire society. Read more about Oriola’s sustainability strategy.